Our RESETTM clinical trials with rese-cel (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, and pemphigus vulgaris are now recruiting.
Recent News View All News
Recent Events View IR Calendar
H.C. Wainwright 28th Annual Global Investment Conference
New York, NY
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings